Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, A-8036, Graz, Austria; General Internal Medicine Practice, Dr. Theodor Körnerstrasse 19b, A-8600, Bruck, Austria.
Institute of Clinical Chemistry and Laboratory Medicine, Hospital Hochsteiermark, Vordernberger Straße 42, 8700, Leoben, Austria.
Clin Nutr ESPEN. 2023 Oct;57:96-105. doi: 10.1016/j.clnesp.2023.06.028. Epub 2023 Jun 28.
Symptoms of the disorders across the irritable bowel syndrome (IBS) spectrum include several different, usually postprandial, abdominal complaints. Up to date, dietary treatments of the IBS have neither been personalized nor diagnosed with sufficient scientific evidence. They have mostly been treated using 'one-size-fits-all' approaches. Such include exclusion diets, a low fermentable oligosaccharides, disaccharides, monosaccharides and polyols diet, and gluten-free diets, lactose-free diets, a diet recommended by the UK National Institute for Health and Care Excellence, and a wheat-free diet. The exact pathophysiology of IBS disorders across the spectrum is still unclear. However, the symptom profile of IBS spectrum disorders seems similar to that of food intolerance/malabsorption syndromes. Celiac disease, fructose malabsorption, histamine intolerance and lactose intolerance represent food intolerance/malabsorption disorders based on the indigestion of sugars and/or proteins. Helicobacter pylori infection may potentially promote the development of IBS and, when facing a case of IBS-like symptoms, a search for intolerance/malabsorption and H. pylori should be added to find the correct treatment for the respective patient. This review will discuss why the 'one-size-fits-all' dietary approach in the treatment of complaints across the IBS spectrum cannot be successful. Hence, it will provide an overview of the most common overall dietary approaches currently used, and why those should be discouraged. Alternatively, a noninvasive diagnostic workup of the pathophysiologic factors of food intolerance/malabsorption in each patient with symptoms of the IBS spectrum is suggested. Additionally, if H. pylori is found, eradication therapy is mandatory, and if food intolerance/malabsorption is detected, an individual and personalized dietary intervention by a registered dietician is recommended.
肠易激综合征(IBS)谱系中各种紊乱的症状包括几种不同的、通常是餐后腹部不适。迄今为止,IBS 的饮食治疗既没有个性化,也没有得到充分的科学证据支持。它们大多采用“一刀切”的方法进行治疗。这些方法包括排除饮食、低可发酵寡糖、双糖、单糖和多元醇饮食、无麸质饮食、无乳糖饮食、英国国家卫生与保健卓越研究所推荐的饮食以及无麦饮食。IBS 谱系紊乱的确切病理生理学仍不清楚。然而,IBS 谱系紊乱的症状谱似乎与食物不耐受/吸收不良综合征相似。乳糜泻、果糖吸收不良、组胺不耐受和乳糖不耐受是基于糖和/或蛋白质消化不良的食物不耐受/吸收不良疾病。幽门螺杆菌感染可能会促进 IBS 的发展,当面对类似于 IBS 的症状时,应增加对不耐受/吸收不良和 H. pylori 的检查,以找到针对特定患者的正确治疗方法。本文综述了为什么不能成功采用“一刀切”的饮食方法来治疗 IBS 谱系中的各种不适症状。因此,本文将概述目前常用的最常见的整体饮食方法,以及为什么应避免使用这些方法。相反,建议对有 IBS 谱系症状的患者进行不耐受/吸收不良的病理生理因素的非侵入性诊断性检查。此外,如果发现 H. pylori,则必须进行根除治疗,如果检测到不耐受/吸收不良,则建议由注册营养师进行个体化和个性化的饮食干预。